The global endometrial ablation market is anticipated to grow at a CAGR of around 5.5% during the forecast period 2021 to 2028 and to reach around US$ 1,372.6 Million by 2028.
|Market||Endometrial Ablation Market|
|Analysis Period||2017 - 2028|
|Forecast Data||2021 - 2028|
|Segments Covered||By Type, By End Use, and By Region|
|Regional Scope||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa|
|Key Companies Profiled||Hologic, Boston Scientific Corporation, Smith & Nephew Plc, The Cooper Companies, Inc., Olympus Corporation, Minerva Surgical, Inc., and Karl Storz|
||Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis|
|Customization Scope||10 hrs of free customization and expert consultation|
Endometrial ablation is a medical technique that involves the removal or destruction of the uterine endometrium in order to cure excessive monthly flow. The primary driver for the market's growth is the rising frequency of gynecological diseases in women, including abnormal vaginal hemorrhage, menorrhagia, cervical cancer etc. According to the World Health Organization, cervical cancer was the 4th most common kind of cancer in women, accounting for 6.6 percent of all female malignancies in 2018. Around 90% of cervical cancer deaths occurred in emerging economies. Additionally, rising demand for less invasive surgical treatments is projected to drive the market's overall growth. Additionally, factors such as technical advancements in endometrial ablation and the advantages of endometrial ablation over surgical treatments contribute to the market's growth. Additionally, endometrial ablation has several advantages over other surgical procedures, including a shorter treatment duration, increased efficiency, faster recovery, reduced invasion, and decreased discomfort. These reasons contribute to the global growth in demand for endometrial ablation. However, the market's expansion is likely to be hampered by rigorous government rules governing the approval of endometrial ablation devices and the hazards involved with endometrial ablation.
COVID 19 Impacts
In the North American region, the US was profoundly affected by the outbreak of COVID-19 pandemic. The country has marked the highest number of positive patients. Across the nation, various healthcare research centers were working only for research on COVID 19 therapeutics. Furthermore, due to changes in customer behaviour regarding the purchase of personal protective equipment during the initial phase of the COVID-19 crisis, demand for endometrial ablation increased dramatically.
Markets in developing countries are expanding
A number of factors, including increasing prevalence of gynecological disorders, rising per capita income, increased public awareness of healthcare devices, and increased investment in the private healthcare sector are driving the demand for endometrial ablation devices in emerging markets such as China, India, and Brazil. Additional factors driving the market expansion in these countries include government initiatives to improve the healthcare system as well as increased research into new minimally invasive ablation surgical techniques.
Segment Analysis By Region
North America is expected to lead the market throughout the forecast period. The endometrial ablation devices market has experienced considerable technological advancements in this field. Increased gynecological disease prevalence, expanding healthcare infrastructure, and the strong establishment of leading market players to deliver new endometrial ablation devices all contribute to the region's endometrial ablation devices market growth. According to the US Department of Health and Human Services, endometriosis affects 11% of females in the US, causing inflammation as the tissue reacts to monthly fluctuations in a woman's menstrual cycle. According to research, the region's large patient pool and rising disposable incomes are driving industry growth.
Asia-Pacific presents appealing opportunities for endometrial ablation device market participants owing to the region's huge population base, growing demand for less invasive treatments, growth of healthcare infrastructure, and higher knowledge of endometrial ablation techniques. Furthermore, an increase in the prevalence of menorrhagia, as well as an increase in demand for sophisticated technologies, are projected to boost market growth. Furthermore, the increased availability of sophisticated endometrial ablation devices in clinics, as well as the expanding number of ambulatory surgical centres, contribute to the growth of the Asia-Pacific endometrial ablation devices market.
The global endometrial ablation market is highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.
Endometrial Ablation Market Segment Analysis, 2020
The global endometrial ablation market is segmented into type, and end use. The type segment is divided into radiofrequency endometrial ablation, cryoablation, electrical ablation, hysteroscopy devices, thermal balloon ablation, hydrothermal ablation, microwave endometrial ablation, others. The application segment is bifurcated into hospitals, clinics, ambulatory surgical centers. Among applications, the hospitals segment is expected to account for significant revenue share in target market. Players operating in the global endometrial ablation market are Hologic, Boston Scientific Corporation, Smith & Nephew Plc, The Cooper Companies, Inc., Olympus Corporation, Minerva Surgical, Inc., and Karl Storz.
Market By Type:
Market By End Use:
Market By Region
The global endometrial ablation market in 2028 is expected to be above US$ 1,372.6 Million.
The CAGR of the global endometrial ablation market from 2021-2028 is above 5.5%.
The primary driver driving the market's growth is the rising frequency of gynecological diseases in women, including abnormal vaginal hemorrhage, menorrhagia, cervical cancer etc.
Hospital segment is growing at faster pace.
In the global market the Asia Pacific region is expected to grow faster.
Some of the players considered in the report scope are Hologic and Boston Scientific Corporation.
The North America is expected to account for significant revenue share in the global market.